Recent developments with Adc Therapeutics SA (ADCT) have led to the company’s beta value being reach 1.50 cents.
On Tuesday, Adc Therapeutics SA (NYSE: ADCT) was 8.41% up from the session before settling in for the closing price of $3.21. A 52-week range